The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as prognostic factor. Additionally, it represents a promising tool for improving therapeutic strategies. In this context, myeloid-derived suppressor cells (MDSCs) have gained a central role in tumor developing with consequent therapeutic implications. In this review, we will focus on the biological and clinical impact of the study of MDSCs in the settings of lymphoid malignancies.
Clinical impact of the immunome in lymphoid malignancies: The role of myeloid-derived suppressor cells
Raccuia SA;
2015
Abstract
The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as prognostic factor. Additionally, it represents a promising tool for improving therapeutic strategies. In this context, myeloid-derived suppressor cells (MDSCs) have gained a central role in tumor developing with consequent therapeutic implications. In this review, we will focus on the biological and clinical impact of the study of MDSCs in the settings of lymphoid malignancies.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_339658-doc_106255.pdf
accesso aperto
Descrizione: Clinical impact of the immunome in lymphoid malignancies: The role of myeloid-derived suppressor cells
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
129.42 kB
Formato
Adobe PDF
|
129.42 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
